Terbinafine Prescribing Guidelines for Pediatric Patients

Required Laboratory Tests and Dosing Considerations

The British Association of Dermatologists recommends baseline liver function tests and a complete blood count before prescribing terbinafine to pediatric patients due to potential hepatotoxicity risks 1, 2
For a pediatric patient weighing over 40 kg, the recommended dose is 250 mg per day, with treatment duration depending on the infection site, typically 6 weeks for fingernail infections and 12 weeks for toenail infections 1, 2
Terbinafine is contraindicated in patients with hepatic impairment, as stated by the British Association of Dermatologists 1, 2
Alternative antifungals such as itraconazole or topical treatments should be considered if laboratory tests reveal pre-existing liver or hematological abnormalities 1, 2
Topical options like amorolfine or ciclopirox may be considered for patients unable to tolerate oral antifungals 1, 2
The British Association of Dermatologists explicitly recommends baseline testing for pediatric patients receiving terbinafine due to its unlicensed use in children and potential hepatotoxicity risks 1, 2
Monitor for taste disturbances, which can be severe and potentially permanent, as reported in clinical guidelines 3